MiR-378a inhibits glucose metabolism by suppressing GLUT1 in prostate cancer

por Cannistraci, A., Hascoet, P., Ali, A., Mundra, P., Clarke, N. W., Pavet, V., Marais, R.
Publicado 2022

Plasminogen activator urokinase expression reveals TRAIL responsiveness and supports fractional survival of cancer cells

por Pavet, V, Shlyakhtina, Y, He, T, Ceschin, D G, Kohonen, P, Perälä, M, Kallioniemi, O, Gronemeyer, H
Publicado 2014